157 related articles for article (PubMed ID: 24817339)
1. Hodgkin lymphoma following adalimumab for the treatment of Crohn's disease in an adolescent.
Rodriguez AA; Kerner J; Luna-Fineman S; Berry GJ
Dig Dis Sci; 2014 Oct; 59(10):2403-5. PubMed ID: 24817339
[No Abstract] [Full Text] [Related]
2. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
McDonnell MJ; Rutherford RM; O'Regan A
J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
[No Abstract] [Full Text] [Related]
3. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
[No Abstract] [Full Text] [Related]
4. Listeria monocytogenes infection in Crohn's disease treated with adalimumab.
Willson KJ; Jacob A; Shetti MP; Bhatia R; Yee K; Osler W
Med J Aust; 2012 Oct; 197(8):466-7. PubMed ID: 23072245
[No Abstract] [Full Text] [Related]
5. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab for the treatment of pediatric Crohn's disease.
Nuti F; Fiorino G; Danese S
Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
[TBL] [Abstract][Full Text] [Related]
7. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
8. [New therapeutic strategy for patients with Crohn's disease using of adalimumab].
Motoya S; Yamashita M; Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):370-7. PubMed ID: 22398901
[No Abstract] [Full Text] [Related]
9. Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.
Cesarini M; Angelucci E; Foglietta T; Vernia P
J Crohns Colitis; 2011 Dec; 5(6):619-22. PubMed ID: 22115384
[TBL] [Abstract][Full Text] [Related]
10. A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.
Reid JD; Bressler B; English J
Can Respir J; 2011; 18(5):262-4. PubMed ID: 21969926
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab-induced psoriasis in a patient with Crohn's disease.
Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
[No Abstract] [Full Text] [Related]
12. Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease.
Eder P; Lykowska-Szuber L; Krela-Kazmierczak I; Stawczyk-Eder K; Linke K
Acta Gastroenterol Belg; 2013 Mar; 76(1):74-5. PubMed ID: 23650791
[No Abstract] [Full Text] [Related]
13. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
Caputo F; Parro S; Zoli G
J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
[No Abstract] [Full Text] [Related]
14. [Efficacy and safety of Adalimumab in Crohn's disease].
Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
[TBL] [Abstract][Full Text] [Related]
15. Monoclonals against TNF are a major advance in the treatment of Crohn's disease.
Fraser A
N Z Med J; 2014 Jun; 127(1396):10-4. PubMed ID: 24997459
[No Abstract] [Full Text] [Related]
16. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease.
Watanabe M; Hibi T; Mostafa NM; Chao J; Arora V; Camez A; Petersson J; Thakkar R
J Crohns Colitis; 2014 Nov; 8(11):1407-16. PubMed ID: 24874893
[TBL] [Abstract][Full Text] [Related]
17. Treating Crohn's disease: at "deep" remission and exploring beyond.
Corte C; Selby WS
Med J Aust; 2012 Oct; 197(8):430-1. PubMed ID: 23072227
[No Abstract] [Full Text] [Related]
18. On the probable association of adalimumab and diffuse retinopathy in a patient with Crohn's disease.
Katsanos A; Asproudis I; Katsanos K; Tsianos EV
J Crohns Colitis; 2013 Feb; 7(1):e22. PubMed ID: 22784948
[No Abstract] [Full Text] [Related]
19. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
Tursi A
J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
[No Abstract] [Full Text] [Related]
20. Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.
Ricart E; Ordás I; Panés J
Gut; 2012 Feb; 61(2):169-70. PubMed ID: 22068167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
